These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 24011634

  • 1. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
    Abulaiti A, Shintani Y, Funaki S, Nakagiri T, Inoue M, Sawabata N, Minami M, Okumura M.
    Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
    [Abstract] [Full Text] [Related]

  • 2. Pulmonary fibroblasts induce epithelial mesenchymal transition and some characteristics of stem cells in non-small cell lung cancer.
    Shintani Y, Abulaiti A, Kimura T, Funaki S, Nakagiri T, Inoue M, Sawabata N, Minami M, Morii E, Okumura M.
    Ann Thorac Surg; 2013 Aug; 96(2):425-33. PubMed ID: 23773734
    [Abstract] [Full Text] [Related]

  • 3. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
    Fujiwara A, Shintani Y, Funaki S, Kawamura T, Kimura T, Minami M, Okumura M.
    Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699
    [Abstract] [Full Text] [Related]

  • 4. IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.
    Shintani Y, Fujiwara A, Kimura T, Kawamura T, Funaki S, Minami M, Okumura M.
    J Thorac Oncol; 2016 Sep; 11(9):1482-92. PubMed ID: 27287412
    [Abstract] [Full Text] [Related]

  • 5. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
    Liu LC, Tsao TC, Hsu SR, Wang HC, Tsai TC, Kao JY, Way TD.
    J Agric Food Chem; 2012 Oct 03; 60(39):9863-73. PubMed ID: 22957988
    [Abstract] [Full Text] [Related]

  • 6. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR, Han SY, Li XH, Zheng WX, Pang LN, Jiang ST, Li PP.
    J Ethnopharmacol; 2017 May 23; 204():45-57. PubMed ID: 28412214
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
    Lee HJ, Park MK, Lee EJ, Lee CH.
    Int J Biochem Cell Biol; 2013 Dec 23; 45(12):2801-7. PubMed ID: 24120851
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
    Da C, Liu Y, Zhan Y, Liu K, Wang R.
    Oncol Rep; 2016 May 23; 35(5):2767-74. PubMed ID: 26986176
    [Abstract] [Full Text] [Related]

  • 13. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Nurwidya F, Takahashi F, Kobayashi I, Murakami A, Kato M, Minakata K, Nara T, Hashimoto M, Yagishita S, Baskoro H, Hidayat M, Shimada N, Takahashi K.
    Biochem Biophys Res Commun; 2014 Dec 12; 455(3-4):332-8. PubMed ID: 25446090
    [Abstract] [Full Text] [Related]

  • 14. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z.
    Respir Res; 2005 Jun 09; 6(1):56. PubMed ID: 15946381
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fibroblasts weaken the anti-tumor effect of gefitinib on co-cultured non-small cell lung cancer cells.
    Yong X, Wang P, Jiang T, Yu W, Shang Y, Han Y, Zhang P, Li Q.
    Chin Med J (Engl); 2014 Jun 09; 127(11):2091-6. PubMed ID: 24890158
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H, Zhang H, Tang L, Chen H, Wu C, Zhao M, Yang Y, Chen X, Liu G.
    Toxicology; 2013 Jan 07; 303():139-46. PubMed ID: 23146760
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.